We hypothesized that hyperresponsiveness in asthma is caused by an impairment in the ability of inspiration to stretch airway smooth muscle. If the hypothesis was correct, we reasoned that the sensitivity to inhaled methacholine in normal and asthmatic subjects should be the same if the challenge was carried out under conditions where deep inspirations were prohibited. 10 asthmatic and 10 normal subjects received increasing concentrations of inhaled methacholine under conditions where forced expirations from a' normal end-tidal inspiration were performed. When no deep inspirations were allowed, the response to methacholine was similar in the normal and asthmatic subjects, compatible with the hypothesis we propose. Completely contrary to our expectations, however, was the marked responsivity to methacholine that remained in the normal subjects after deep breaths were initiated. 6 of the 10 normal subjects had > 20% reduction in forced expiratory volume in one second (FEV 1) at doses of methacholine < 8 mg/ml, whereas there was < 15% reduction with 75 mg/ml during routine challenge. The ability of normal subjects to develop asthmatic responses when the modulating effects of increases in lung volume was voluntarily suppressed suggests that an intrinsic impairment of the ability of inspiration to stretch airway smooth muscle is a major feature of asthma. (J. Clin. Invest. 1995Invest. . 96:2393Invest. -2403
Introduction
In 1961, Nadel and Tierney showed that while a deep inspiration did not alter airway resistance measured at functional residual capacity in the control state, it always reduced it for 1-2 min when bronchoconstriction was present (1) . In 1981, Fish et al. 1 . Abbreviations used in this paper: r, time constant; DI, deep inspiration; FEV,, forced expiratory volume in one second; FVC, forced vital capacity; IVC, inspiratory vital capacity; Mch, methacholine; MMEF, mid maximal expiratory flow; PC, provocative concentration; RV, residual volume; TLC, total lung capacity.
confirmed the findings of Nadel and Tierney in nonasthmatic subjects following a challenge with methacholine (Mch),' but the effect of a deep inspiration was much less in asthmatic subjects (2) . Fish et al. felt that there was an intrinsic means of regulating bronchomotor tone by active changes in lung volume in normal subjects, but the mechanism was somehow impaired in asthma. They suggested, "that airway hyperreactivity in asthma is perhaps less a reflection of enhanced end-organ responsiveness than a reflection of this impaired capacity." The observations of Nadel and Tierney and Fish et al. in normal subjects could be explained by the stretch of constricted airway smooth muscle causing a transient reduction in smooth muscle tone (3) . Fish et al. suggested that the major problem in asthma might be an impairment in the ability of inspiration to stretch the airway smooth muscle (3, 4) . This was in keeping with the findings of Colebatch et al. in 1973 (5) who observed that there was a much smaller decrease in pulmonary resistance with lung inflation in asthmatic than healthy subjects; and they suggested that this was due to an "increased rigidity of the airways." In 1974, Green and Mead speculated that "perhaps in patients with asthma maximal inspiration is unable to dilate the airways completely," (6) .
If the hypothesis of Fish et al. were correct, normal subjects should respond like asthmatic subjects to airway smooth muscle constrictors if the challenge could be carried out under conditions where the bronchodilating effects of deep inspiration in the normal subjects could be suppressed. This is a corollary of the hypothesis of Fish et al., and the testing of this corollary was the aim of the present study.
We measured the response to increasing concentrations of Mch in both normal and asthmatic subjects in a protocol where deep breaths were prohibited so that lung volumes never increased above the volume at a normal end-tidal inspiration. Under these conditions the response to increasing concentrations of Mch was similar in the normal and asthmatic subjects, compatible with the corollary hypothesis. What was especially surprising and provocative was that the effect of Mch in the normal subjects was markedly exaggerated even after deep breaths, as in asthma, after the prolonged inhibition of deep breaths during the challenge; whereas, we had expected a completely normal response once the deep breaths were initiated in the normal subjects. The ability of normal subjects to develop asthmatic responses when the modulating effect of increases in lung volume was voluntarily suppressed for prolonged periods of time suggests that the intrinsic impairment of the same modulating effect in asthma may be a major feature of the disease.
Methods
This study was approved by the Institutional Review Board of the Johns Hopkins Bayview Medical Center. Informed, written consent was obtained from each subject before enrollment. 
Subjects
We studied 10 asthmatics and 10 nonasthmatics ranging in age from 24 to 49 yr old (Table I) . Asthmatic subjects fulfilled the diagnostic criteria of the American Thoracic Society (7) and were randomly selected from a large database of allergic/asthmatic individuals recruited from the community by radio/newspaper advertising. Nonasthmatic subjects were all employees of Johns Hopkins University. They reported no symptoms consistent with asthma and had never received the diagnosis of asthma from a physician. All subjects were screened by completing an asthma symptom questionnaire and undergoing allergy skin testing and routine Mch inhalation challenge. There was no significant difference in the mean age of the two groups. All 10 asthmatic subjects had multiple positive skin prick tests to common allergens and reacted to Mch with a provocative concentration (PC20) < 1 mg/ml. The asthmatic subjects had significantly lower forced expiratory volume (FEVy)% predicted, forced vital capacity (FVC)% predicted, and FEVI/FVC compared to the normal subjects (P < 0.002, P < 0.02, and P < 0.01, respectively). Three of the nonasthmatic subjects had positive skin prick tests but not related to any upper or lower respiratory symptoms. All of the normal subjects received the highest concentrations of Mch in the challenge (75 mg/ml) with no more than 15% reduction in FEV1. All subjects were nonsmokers, had been free of upper respiratory infection for at least 4 wk before evaluation, and abstained from caffeine on Mch challenge testing days. Asthmatic subjects withheld all asthma medications before being studied (48 h for theophylline preparations and 8 h for inhaled /3-agonists).
Study design
The study required a total of two visits to the laboratory. On one visit, all subjects underwent a screening evaluation as described above. Routine methacholine challenge. [RV(P -M) I The difference in residual volumes between that obtained after the partial expiratory maneuver and that after the maximal expiratory maneuver. tion) (Fig. 1) . The partial and maximal forced expirations could be displayed as volume versus time ( Fig. 1 A) or flow versus volume (Fig. 1 B) (10) . This index (Tr) is directly related to the product of the average values of lung compliance and resistance to flow between the alveoli and the site of flow limitation in the airways (10, 11I) . Since the baseline values of i-were different in the asthmatic and normal subjects, we used the fractional change in r from baseline (the ratio of the difference between r at a specific dose of Mch and -r at baseline relative to the baseline T) as our primary outcome value (this is the percent change divided by 100).
Evaluation of changes in residual volume. We assumed that TLC remained constant during challenge (12) . We also assumed that changes in the volume inspired from RV to TLC, the inspiratory vital capacity (IVC), are equal to the changes in RV that occurred during the period of challenge where deep breaths were prohibited and that, after deep inspiration maneuvers, the changes in FVC were equal to the changes in RV. The change in IVC was measured as follows: from each combination maneuver the difference in the RV between the partial and the maximal expiration [RV (P -M)]I was calculated from the flow-volume curves ( Fig. 1 B) . The IVC was measured by subtracting RV(P -M) from FVC ( Fig. 1 A) . In the initial combination maneuvers, the average RV (P -M) from the three reproducible curves was subtracted from the average FVC for the measurement of IVC. The IVC for each of the three combination maneuvers that was performed after the highest dose of Mch was calculated independently.
Evaluation of changes in isovolume flow. With the assumption of constant TLC, we linearized the flow-volume curve by a straight line from RV with a slope of 1 Ir. The decrease in isovolume flow is then a function both of the increase in i-and the increase in RV. The ratio of flow at the highest Mch dose to the flow at baseline at a forced expired volume one-half of the baseline FVC (from TLC) was the index used. This ratio was estimated both for the partial maneuver (R,'.5p) and the first maximal breath (R4~.5m) from the combination maneuvers.
Statistical analysis. 0.39±1.47 mg/ml, P < 0.0001). The baseline partial FEVI/ FVC was significantly greater in the normal than the asthmatic subjects and the partial T, significantly less (P < 0.002). Thus, the fractional response in ir was considerably greater in the normal subjects (P < 0.005). Considering response a function of fractional change rather than end-point reached, the greater fractional change in the normal subjects is in keeping with the greater dose of Mch.
The response of the normal and asthmatic subjects during the prohibition of DI was compared by examining the fractional change in r at the same dose level in both groups. Both groups could be compared up to the level of 0.25 mg/ml. This level was reached by all of the normal subjects and by 9 of the 10 the first full breath that followed the prohibition of DI. From the changes in r and RV, R4.5p and R4.5M were also calculated.
-e 2. Dose response curves of the methacholine-induced fractional
The fractional change from baseline in was significantly es in the index T from baseline (r after methacholine minus T at ne divided by r at baseline) in the normal and in the asthmatic reduced by DI only in the normal subjects (Fig. 3) . Similarly, :ts, during the modified methacholine challenge protocol (deep the change in RV was significantly reduced by DI only in the is prohibited). Values represent means±SEM. In addition to the normal subjects (Fig. 4 A) . However, in the normal subjects, s at each concentration of methacholine, the figure depicts the T was still significantly elevated over baseline and a large in- > 0 only in the normal subjects (Fig. 4 C) subjects, but this effect was absent in the asthmatic subjects (Fig. 5) . The change in FEV1 and FVC with Mch was much greater in the modified than the routine challenge in the normal subjects, but this was not so for the asthmatic subjects (Fig. 6, A and  B) . The increased response in the modified challenge in the normal subjects was associated with a smaller dose of Mch. Indeed, in the modified challenge, 6 of the 10 normal subjects reached the challenge endpoint at a dose conventionally considered within the asthmatic range (< 8 mg/ml). In contrast, in the asthmatic group, the same number of doses of Mch were used to reach the endpoint in both the routine and the modified challenge (Fig. 6 C) . In the modified challenge, the fractional change from baseline in both FEV1 and FVC became less with subsequent breaths in both the normal and the asthmatic subjects, but the effect of the subsequent breaths in increasing FEV, and FVC was not significantly different between the normal and the asthmatic subjects (Table IV) . However, there was borderline statistical significant (P = 0.1 1 ) for the group/breath interaction in this analysis. The difference between the modified and routine challenge in the normal subjects was still significant if the third (instead of the first) full breath that followed the modified challenge was used for both FEVI (P < 0.05) and FVC (P < 0.02) (data not shown).
Two additional studies were carried out on a subset of normal and asthmatic subjects to rule out any direct effect of the prohibition of DI. We repeated the modified challenge substituting diluent for Mch, and found that prohibition of DI in itself did not cause a significant decrease in pulmonary function (partial FEV1/FVC) in either the nonasthmatic subjects (n = 5) or asthmatics (n = 4). The partial FEV1/FVC after the first dose of diluent compared to the last dose of diluent (five doses given to the nonasthmatics and four to the asthmatics) was 0.74±0.04 versus 0.76±0.04 in the nonasthmatics and 0.67±0.01 versus 0.68±0.02 in the asthmatics.
In five normal subjects and six asthmatic subjects, we car- 
Discussion
The hypothesis that led to this study, that hyperresponsiveness in asthma is caused by impaired ability of DI to dilate the airways, is fully supported by our primary findings: (a) in the absence of DI, the airway response to Mch is similar in asthmatics and nonasthmatics, and (b) in nonasthmatics, DI has a striking effect in preventing Mch-induced bronchoconstriction, but DI has no influence on the response to Mch-induced bronchoconstriction in asthmatic subjects. All of the normal subjects and 9 out of 10 of the asthmatic subjects inhaled the same concentrations of Mch up to the level of 0.25 mg/ml. Over this range, the fractional change in r was virtually identical in both groups with a threshold of 0.075 mg/ ml. The design of the study was such that we did not determine the change in RV until higher concentrations were reached in both groups of subjects. It is possible that the change in RV was greater in the asthmatic than the normal subjects at the same dose of Mch in spite of the same change in 1. If this were so, and since the change in isovolume flow is a function of the change in RV and the change in T, there would have been a greater decrease in isovolume flow in the asthmatic subjects compared to the normal subjects.
The isovolume flows of the linearized flow-volume curves are given by the following equations: (Fig. 1 B) . The smaller each factor, the greater the effect on isovolume flow. In the asthmatic subjects, I6RV was significantly less than jAT, both on the partial and the full maneuvers (P < 0.02 anda 2 I (Table IV) . In other words, not only does bronchoconstriction take place when the spasmogen is delivered in the absence of DI, but the ability of a healthy person to reverse the bronchoconstriction with a DI is strikingly reduced. This serendipitous observation is further substantiated when we compare our findings to those of two other studies in which the effects of DI on Mch-induced changes in RV were examined in normal and asthmatic subjects by the same method we used, that is, differences in IVC and FVC with the assumption of constant TLC (we are unaware of any studies other than ours where the time relations of a forced expiration were used to study the effects of DI).
In a recent study of Pellegrino et al. (13) , the effect of DI on the fractional change in RV relative to baseline FVC was significantly greater in normal than in asthmatic subjects, qualitatively similar to the results of our study. In the normal subjects of their study, however, there was a much greater decrease in RV after DI than was found in our current study (P < 0.001 by an unpaired t test). Further, after DI in the normal subjects, the fractional increase in RV at the highest level of Mch was only 0.09 in the study of Pellegrino et al. in comparison to a fractional change of 0.26 in our current study. This difference was highly significant (P < 0.005) in spite of a significantly lower dose of Mch in our modified challenge in comparison to Pellegrino's study.
In a study of Wheatley et al. (14) , the decrease in RV produced by DI relative to the change in RV before DI (the same index as in our Fig. 4 C) was much greater in their normal subjects than we found in ours. (They used a slightly different index, but the index in Fig. 4 C can be calculated for each of the subjects they studied.) In their study, the ratio was 0.80 and in our study only 0.23 (P < 0.00005). Thus, the reversal by DI of the increase in RV in their normal subjects was nearly complete (80% reversal) in contrast to < 25% reversal in ours. As in our study, they found no significant reversal in asthmatic subjects.
In the studies of Pellegrino et al. the decrease in FEVI and FVC in the modified versus the routine challenge in the normal subjects in our study (Fig. 6 ) and the rather slow improvement with the second and third full breaths (Table IV) .
In the absence of DI during the inhalation of increasing concentrations of Mch, we believe that the repetitive partial forced expirations to RV are a necessity to produce marked responses in normal subjects. The If the bronchodilating mechanism of DI is from stretch of the smooth muscle leading to stress relaxation, in keeping with the in vitro studies of Gunst et al. (18, 19) , the attenuation of this mechanism in asthmatic subjects could be due to an increased stiffness of the airway wall, as suggested by the studies of Colebatch et al. (5) . The asthmatic airway has increased thickness of the smooth muscle layer, increased collagen deposits beneath the basement membrane, and variable amounts of inflammatory products in the wall (20) . It is also possible that the force dilating the airway is diminished in asthma. The mechanism by which intrapulmonary airways and smooth muscle within their walls are stretched by inspiration is largely due to the increase in radial traction on the airways exerted by the surrounding lung parenchyma (21) (22) (23) . Edema of the airway wall or in the peribronchial space could unlink the interdependence between the airway and parenchyma resulting in a decrease in radial force acting on the smooth muscle with DI (24, 25) . Ingram considered the interaction between the airways and lung parenchyma and proposed that the attenuated response to DI in asthma is due to a problem of increased parenchymal relative to airway hysteresis (26, 27) .
Some consideration must be given to the possibility that the ineffectiveness of DI in asthmatic subjects is not due to a decrease in the stretch of smooth muscle. Even if DI produced the same degree of stretch in both groups, it is possible that the problem of asthma is a lack of responsiveness of the smooth muscle to stretch, either an intrinsic problem of asthmatic smooth muscle or a result of humoral inflammatory factors. Indeed, it has been suggested that asthmatic smooth muscle might show a myogenic response with an increase in tone accompanying stretch as in vascular smooth muscle, but this myogenic response is absent in nonasthmatic airways (28, 29) . It is also possible that DI produces bronchodilatation through neural or humoral elements in normal subjects that are absent in asthmatic subjects. In a recent study of Malmberg et al. (30) , a DI before the administration of Mch, in normal subjects, protected their airways from bronchoconstriction. This effect was even more pronounced than the effect of a DI after the administration of Mch. The mechanism is unknown, but is compatible with the release of an unknown bronchodilator by DI before the administration of Mch. Whatever the cause of the apparent ineffectiveness of changes in lung volume to modulate airway smooth muscle tension in asthma, the lack of this important bronchodilating mechanism can explain the paradox of the dose-response curve in nonasthmatic subjects reaching a plateau with minimal changes in pulmonary function (31) (32) (33) in spite of complete closure of airways occurring at high transmural pressures in vitro (16, 17) . Conditions associated with limited changes in lung volume might be expected to demonstrate increased airways responsiveness to bronchoconstrictors. For example, there is a recent report that in cervical spinal cord injury, where there is a reduction in FVC and inspiratory capacity, there is a marked increase in responsiveness to Mch (34) .
In conclusion, we have demonstrated that the bronchodilating effect of DI is a major feature differentiating the normal from the asthmatic state. DI does not appear to have significant effects on the asthmatic airway. In the presence of DI, nonasthmatics are resistant to bronchoconstriction; in the absence of DI, bronchoconstriction can occur in the nonasthmatics to the same extent as in the asthmatics. We propose that this difference in response to DI is the major contributor to the hyperresponsiveness in asthma. The reason for the marked difference in the response to DI between normal and asthmatic subjects is not clear.
